Alexander Seibold

496 total citations
13 papers, 299 citations indexed

About

Alexander Seibold is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Alexander Seibold has authored 13 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Alexander Seibold's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (6 papers) and Diabetes and associated disorders (4 papers). Alexander Seibold is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (6 papers) and Diabetes and associated disorders (4 papers). Alexander Seibold collaborates with scholars based in Germany, United Kingdom and Spain. Alexander Seibold's co-authors include Mark L. Evans, Pratik Choudhary, Birgit Rami‐Merhar, Fernando Gómez‐Peralta, Emmanuel Cosson, Concetta Irace, Stefano Del Prato, Éric Renard, Ludger Rose and Manel Puig‐Domingo and has published in prestigious journals such as Diabetes, Journal of Allergy and Clinical Immunology and Diabetologia.

In The Last Decade

Alexander Seibold

12 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Seibold Germany 6 264 148 129 25 11 13 299
Tomas C. Walker United States 11 272 1.0× 161 1.1× 154 1.2× 39 1.6× 15 1.4× 23 325
Fleur Levrat‐Guillen United Kingdom 10 307 1.2× 167 1.1× 128 1.0× 26 1.0× 5 0.5× 21 337
Pauline Schaepelynck France 12 275 1.0× 137 0.9× 165 1.3× 50 2.0× 11 1.0× 21 333
Yongjin Xu United States 11 442 1.7× 272 1.8× 247 1.9× 30 1.2× 13 1.2× 26 470
G Faber-Heinemann Germany 4 378 1.4× 248 1.7× 241 1.9× 16 0.6× 5 0.5× 5 409
Grenye O’Malley United States 9 206 0.8× 103 0.7× 115 0.9× 16 0.6× 4 0.4× 25 276
Ingrid Schütz-Fuhrmann Austria 7 507 1.9× 325 2.2× 377 2.9× 26 1.0× 13 1.2× 15 568
Alexander Abitbol Canada 9 222 0.8× 86 0.6× 107 0.8× 12 0.5× 14 1.3× 19 250
Augustin Brooks United Kingdom 8 172 0.7× 111 0.8× 123 1.0× 11 0.4× 8 0.7× 20 220
Barbora Paldus Australia 12 289 1.1× 165 1.1× 204 1.6× 16 0.6× 8 0.7× 27 311

Countries citing papers authored by Alexander Seibold

Since Specialization
Citations

This map shows the geographic impact of Alexander Seibold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Seibold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Seibold more than expected).

Fields of papers citing papers by Alexander Seibold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Seibold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Seibold. The network helps show where Alexander Seibold may publish in the future.

Co-authorship network of co-authors of Alexander Seibold

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Seibold. A scholar is included among the top collaborators of Alexander Seibold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Seibold. Alexander Seibold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Evans, Mark L., et al.. (2022). Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies. Diabetes Therapy. 13(6). 1175–1185. 32 indexed citations
3.
Gómez‐Peralta, Fernando, Pratik Choudhary, Emmanuel Cosson, et al.. (2022). Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obesity and Metabolism. 24(4). 599–608. 63 indexed citations
4.
Seibold, Alexander. (2021). Minimizing Adverse Skin Reactions to Wearable Continuous Glucose Monitoring Sensors in Patients With Diabetes. Journal of Diabetes Science and Technology. 15(3). 713–714. 6 indexed citations
5.
Danne, Thomas, Catarina Limbert, Manel Puig‐Domingo, et al.. (2021). Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future. Diabetes Therapy. 12(9). 2289–2310. 32 indexed citations
6.
Rose, Ludger, Gerhard Klausmann, & Alexander Seibold. (2020). Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres. Diabetes Therapy. 12(1). 363–372. 15 indexed citations
7.
8.
Seufert, Jochen, Dorothee Deiss, Stefan Gölz, et al.. (2019). Neue Therapieoptionen mit kontinuierlich gemessenen Glukosedaten – Empfehlungen für die Praxis. Diabetologie und Stoffwechsel. 14(5). 388–398. 3 indexed citations
9.
Seibold, Alexander, et al.. (2019). Performance of Freestyle Libre® 2 System in Adult and Pediatric Populations. Diabetologie und Stoffwechsel. 1 indexed citations
10.
11.
Berdyshev, Evgeny, Elena Goleva, Irina Bronova, et al.. (2017). Lipid Abnormalities Associated with Skin Lesions in Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 139(2). AB87–AB87. 2 indexed citations
12.
Kistner, Anna, et al.. (1996). Extended physiological models for the simulation of the glucose metabolism. 2(1). 41–54. 3 indexed citations
13.
Jehle, P. M., et al.. (1996). Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus.. PubMed. 34(11). 498–503. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomas C. Walker Breakdown of academic impact, for papers by Fleur Levrat‐Guillen Breakdown of academic impact, for papers by Pauline Schaepelynck Breakdown of academic impact, for papers by Yongjin Xu Breakdown of academic impact, for papers by G Faber-Heinemann Breakdown of academic impact, for papers by Grenye O’Malley Breakdown of academic impact, for papers by Ingrid Schütz-Fuhrmann Breakdown of academic impact, for papers by Alexander Abitbol Breakdown of academic impact, for papers by Augustin Brooks Breakdown of academic impact, for papers by Barbora Paldus
Rankless by CCL
2026